Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis. [electronic resource]
Producer: 20061027Description: 322-3 p. digitalISSN:- 0300-9742
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- complications
- Demyelinating Diseases -- chemically induced
- Etanercept
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Injections, Subcutaneous -- adverse effects
- Middle Aged
- Receptors, Tumor Necrosis Factor
- Vasculitis, Leukocytoclastic, Cutaneous -- chemically induced
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.